[email protected]
@julienpaccoujp7
Professor of Rheumatology
ID: 1476505082850123776
30-12-2021 10:47:49
259 Tweet
227 Followers
319 Following
Submit your abstract for #BMA2024 in Montreal, Canada! Abstract submission deadline: 15th May! You have the option to attend our meeting in person or virtually Visit our website for further info bma-society.org/bma-2024/ Gustavo Duque Bram van der Eerden IFMRS ECTS ASBMR
Very clear and comprehensive presentation of the novel ECTS recommendations for GIOP by Drs.Paccou and Yavropoulou: special focus on screening and treatment according to fracture risk and areas of uncertainty. [email protected] Lars Folkestad ECTS_Science ECTS Academy
ECTS Pre-Congress Day beginning with a 🇫🇷National Day on Nutrion and Aging effects on Bone-Prof Paccou [email protected] presenting the GRIO recommendations-of calcium, protein, tea, coffee, beer and 🦴😉#ECTS2024
Kicking off #ECTS2024 with an Open Forum on diabetes and bone. ECTS Academy members Michaela Tencerová, Morten Frost Nielsen and Julien Paccou delivering terrific talks! Thought-provoking questions from the audience. Mind the fat! BMAS ECTS ECTS_Science
We are live at ECTS pre-congress with the Open forum: "BMA, stem cells and hematopoietic interactions within the bone marrow niche" Great lineup of speakers with Tom Ambrosi Olaia Naveiras and Michaela Reagan Session chaired by Bram van der Eerden Annegreet Vlug ECTS_Science
Join us for Dr. Gustavo Duque (Gustavo Duque) Visiting Scholar online lecture on #Geroscience: The New Frontier in Aging and Research and Clinical Care. Registration is free and open to all! 🌟 🗓️ Date: June 4, 2024 🕛 Time: 12:00-1:00 PM EDT 🔗 Register here:
The Hamilton Health Sciences Pan Canadian Research Connect is thrilled to co-host an exclusive #free webinar on #Geroscience with the @GerasCentre and Regional Geriatric Program Central (RGPc), featuring Professor Gustavo Duque! Earn 1.0 hours CE credit with SOCRA 🇨🇦 🗓️ Date: June 4th, 2024 🕛 Time: 12:00 – 13:00
📣 Late-breaking abstracts now open #ASBMR2024 ASBMR Sun H. Peck Laura Calvi Emily Quarato Noriaki Ono Angela M. Cheung Danielle Whittier, PhD Mary L. Bouxsein, PhD Patricia Juárez Camacho, PhD Rachelle Johnson Naomi Dirckx Garyfallia (Fay) Papaioannou Madhura Nijsure Shawn Hallett Jakob Höppner A/Prof Michelle McDonald Christa Maes Rajesh Jain MD
pubmed.ncbi.nlm.nih.gov/38938063/ Osteoanabolics are 1st line therapy of severe osteoporosis but how to choose which one to deploy first? Covered this topic with great collaborators& friends [email protected] Anda Naciu Athan. Anastasilakis-hope will be useful for clinicians! European Society of Endocrinology (ESE)
#Bone health in adults with #obesity before and after interventions to promote weight loss The Lancet Diabetes & Endocrinology [email protected] thelancet.com/journals/landi…
Osteoanabolic drugs are becoming first-line therapy for severe osteoporosis:in this review we provide guidance on how to choose between them. Delighted to draft this with my good friends& collaborators Athan. Anastasilakis [email protected] Anda Naciu Maria Yavropoulou European Society of Endocrinology (ESE)